| ![]() | SMTL ID3ztd.1LigandsMETHYL 4-[({(4R)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-L-PROLYL}AMINO)METHYL]BENZOATEPolypeptidesTRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2; TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1; VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOROligo-statehetero-1-1-1-mer
 | 
| ![]() | SMTL ID3ztd.2LigandsMETHYL 4-[({(4R)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-L-PROLYL}AMINO)METHYL]BENZOATEPolypeptidesTRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2; TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1; VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOROligo-statehetero-1-1-1-mer
 | 
| ![]() | SMTL ID3ztd.3LigandsMETHYL 4-[({(4R)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-L-PROLYL}AMINO)METHYL]BENZOATEPolypeptidesTRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2; TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1; VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOROligo-statehetero-1-1-1-mer
 | 
| ![]() | SMTL ID3ztd.4LigandsMETHYL 4-[({(4R)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-L-PROLYL}AMINO)METHYL]BENZOATEPolypeptidesTRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2; TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1; VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOROligo-statehetero-1-1-1-mer
 |